FDA advisors overwhelmingly endorse Novavax COVID-19 vaccine

FDA advisors overwhelmingly endorse Novavax COVID-19 vaccine

Ars Technica

Published

The company hopes it will sway vaccine holdouts to finally get their shots.

Full Article